Terms: = Bone cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802
336 results:
1. Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report.
Inakami K; Fujita N; Iguchi C; Enomoto Y; Minohata J; Sata A; Miyagawa Y; Yanagisawa T; Saitoh T; Nomura T; Sawai Y; Takahara K; Kasugai T; Shiba E
J Med Case Rep; 2024 May; 18(1):214. PubMed ID: 38689362
[TBL] [Abstract] [Full Text] [Related]
2. Vitexicarpin Induces Apoptosis and Inhibits Metastatic Properties via the AKT-PRAS40 Pathway in Human Osteosarcoma.
Yun HM; Kwon HS; Lee JY; Park KR
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612399
[TBL] [Abstract] [Full Text] [Related]
3. Circ_0002669 promotes osteosarcoma tumorigenesis through directly binding to MYCBP and sponging miR-889-3p.
Zhang Y; Zhan Y; Liu Z; Guo H; Liu D; Chen C
Biol Direct; 2024 Apr; 19(1):25. PubMed ID: 38570856
[TBL] [Abstract] [Full Text] [Related]
4. Combined SET7/9 and cdk4 inhibition act synergistically against osteosarcoma.
Shi Y; Wang Z; Shao Y; Guang Q; Zhang J; Liu B; Wu C; Wang Y; Sui P
Biochem Biophys Res Commun; 2024 May; 708():149808. PubMed ID: 38520914
[TBL] [Abstract] [Full Text] [Related]
5. [Recurrent Breast cancer with bone Metastasis Effectively Treated with Abemaciclib plus Endocrine Therapy-A Case Report].
Adachi K; Nagae J; Kubota H; Suzuki S; Hirano T; Sakurai K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1845-1847. PubMed ID: 38303227
[TBL] [Abstract] [Full Text] [Related]
6. [bone Marrow Carcinomatosis with Disseminated Intravascular Coagulation in a Breast cancer Patient Treated with Chemotherapy and cdk4/6 Inhibitor].
Kume S; Makino T; Goto A; Onodera Y; Kudo S
Gan To Kagaku Ryoho; 2023 Dec; 50(12):1331-1333. PubMed ID: 38247075
[TBL] [Abstract] [Full Text] [Related]
7. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract] [Full Text] [Related]
8. Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers.
Payton M; Belmontes B; Hanestad K; Moriguchi J; Chen K; McCarter JD; Chung G; Ninniri MS; Sun J; Manoukian R; Chambers S; Ho SM; Kurzeja RJM; Edson KZ; Dahal UP; Wu T; Wannberg S; Beltran PJ; Canon J; Boghossian AS; Rees MG; Ronan MM; Roth JA; Minocherhomji S; Bourbeau MP; Allen JR; Coxon A; Tamayo NA; Hughes PE
Nat Cancer; 2024 Jan; 5(1):66-84. PubMed ID: 38151625
[TBL] [Abstract] [Full Text] [Related]
9. Induced Endothelial Cell Cycle Arrest Prevents Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
Genet G; Genet N; Paila U; Cain SR; Cwiek A; Chavkin NW; Serbulea V; Figueras A; Cerdà P; McDonnell SP; Sankaranarayanan D; Huba M; Nelson EA; Riera-Mestre A; Hirschi KK
Circulation; 2024 Mar; 149(12):944-962. PubMed ID: 38126211
[TBL] [Abstract] [Full Text] [Related]
10. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract] [Full Text] [Related]
11. Interstitial lung disease and cdk4/6 inhibitors in the treatment of breast cancer.
Schlam I; Giordano A; Tolaney SM
Expert Opin Drug Saf; 2023; 22(12):1149-1156. PubMed ID: 37994878
[TBL] [Abstract] [Full Text] [Related]
12. A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent cancer Cells.
Calvo V; Zheng W; Adam-Artigues A; Staschke KA; Huang X; Cheung JF; Nobre AR; Fujisawa S; Liu D; Fumagalli M; Surguladze D; Stokes ME; Nowacek A; Mulvihill M; Farias EF; Aguirre-Ghiso JA
Clin Cancer Res; 2023 Dec; 29(24):5155-5172. PubMed ID: 37982738
[TBL] [Abstract] [Full Text] [Related]
13. CDK6: an attractive therapeutic target for T-ALL/LBL.
Li W; Hu JK; Hu MG
Expert Opin Ther Targets; 2023; 27(11):1087-1096. PubMed ID: 37975616
[TBL] [Abstract] [Full Text] [Related]
14. Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast cancer: A Retrospective Analysis of the MONARCH 2 Trial.
Gerratana L; Kocherginsky M; Davis AA; D'Amico P; Reduzzi C; Puglisi F; Cristofanilli M
Oncologist; 2024 Feb; 29(2):123-131. PubMed ID: 37935631
[TBL] [Abstract] [Full Text] [Related]
15. Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically Heterogeneous.
Difilippo V; Saba KH; Styring E; Magnusson L; Nilsson J; Nathrath M; Baumhoer D; Nord KH
Lab Invest; 2024 Jan; 104(1):100283. PubMed ID: 37931683
[TBL] [Abstract] [Full Text] [Related]
16. A new perspective on the proper timing of radiotherapy during cdk4/6 inhibitor therapy in patients with "bone-only" metastatic breast cancer.
Tornyi I; Árkosy P; Horváth I; Furka A
Pathol Oncol Res; 2023; 29():1611369. PubMed ID: 37886029
[TBL] [Abstract] [Full Text] [Related]
17. Bruceine A: Suppressing metastasis via MEK/ERK pathway and invoking mitochondrial apoptosis in triple-negative breast cancer.
Li X; Liu C; Zhang X; Sun C; Ling J; Liu Y; Zuo Y; Cao Y; Zhang C; Jiang T; Wang M; Liu J; Lu J
Biomed Pharmacother; 2023 Dec; 168():115784. PubMed ID: 37879215
[TBL] [Abstract] [Full Text] [Related]
18. Phase II trial of cdk4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of cdk4/ CDKN2A.
Martin-Broto J; Martinez-Garcia J; Moura DS; Redondo A; Gutierrez A; Lopez-Pousa A; Martinez-Trufero J; Sevilla I; Diaz-Beveridge R; Solis-Hernandez MP; Carnero A; Perez M; Marcilla D; Garcia-Foncillas J; Romero P; Fernandez-Jara J; Lopez-Lopez D; Arribas I; Hindi N
Signal Transduct Target Ther; 2023 Oct; 8(1):405. PubMed ID: 37875500
[TBL] [Abstract] [Full Text] [Related]
19. The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical Implications.
Denu RA; Moyers JT; Gouda MA; Conley AP; Lazar AJ; Subbiah V
Clin Cancer Res; 2023 Nov; 29(22):4669-4678. PubMed ID: 37643131
[TBL] [Abstract] [Full Text] [Related]
20. KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma.
Motoi T; Hirata M; Kukita Y; Satomi K; Tamura H; Adachi S; Matsushita Y; Horiguchi SI; Hishima T; Ikegami M; Okuma T; Tao K; Arakawa A; Ogawa C; Matsuda K; Ichimura K; Nakamura H; Mori T; Yoshida A
Mod Pathol; 2023 Nov; 36(11):100317. PubMed ID: 37634866
[TBL] [Abstract] [Full Text] [Related]
[Next]